- J.D., Columbia University, 1995, Harlan Fiske Stone Scholar 1993-1995, Submissions and Articles Editor, Columbia Journal of Transnational Law
- S.B., Massachusetts Institute of Technology, 1992, National Merit Scholar
- District of Columbia
Bevin Newman is a partner in the Antitrust and Competition Practice Group in the firm's Washington, D.C. office.
Areas of Practice
Bevin is a leading authority on antitrust in healthcare and has worked with clients covering every aspect of this rapidly evolving industry for 20 years. She advises and defends health systems, hospitals, academic medical centers, providers, payers, and pharmaceutical companies undertaking significant transactions, including mergers, joint ventures, intellectual property licenses, and a variety of innovative affiliations and collaborations, as well as counseling on conduct matters. Bevin also has extensive experience coordinating the antitrust and regulatory reviews of multijurisdictional transactions for U.S. and foreign clients in the energy, technology, and pharmaceuticals fields. She is one of the most knowledgeable Hart-Scott-Rodino Act (HSR Act) practitioners in the country and also represents clients before the Committee on Foreign Investment in the United States (CFIUS).
Bevin has advised on multiple antitrust matters for Caremark, UPMC, Duke University, Atlantic Health System, Yale-New Haven Health System, Centura, SSM Health, UnityPoint, Abbot Laboratories, Boehringer Ingelheim, and Bon Secours Health System.
Bevin writes and speaks frequently on antitrust issues in healthcare. Bevin's publications include Antitrust Aspects of Mergers and Acquisitions (BNA Corp. Practice Series) and "An Overview of Federal Antitrust Laws and Enforcement Policies" (CCH Healthcare Compliance Professionals Manual). She served on the editorial board for the ABA's Antitrust Compliance and is a member of the Antitrust Section of the ABA and the American Health Lawyers Association.
- Duke University Health System and WakeMed Health enter into heart and cancer service line revenue mergers - Represented Duke University Health System and WakeMed Health in creating joint operating agreements for the collaboration of both Cancer Care Plus+ and Heart Care Plus+.
- Celularity acquires certain assets from TNK Therapeutics - Advised Celularity Inc. in connection with its acquisition from TNK Therapeutics of certain intellectual property rights related to TNK's proprietary chimeric antigen receptor ("CAR") constructs and related CARs.
- Sumitomo Dainippon Pharma acquires Tolero Pharmaceuticals, Inc. - Advised Sumitomo Dainippon Pharma Co. Ltd., a leading pharmaceutical company based in Japan, in its acquisition of Tolero Pharmaceuticals, Inc.
- Investcorp International acquires Agromillora Catalana - Advised Investcorp International Ltd. in its acquisition of a majority stake in Agromillora Catalana, S.A., parent holding company of an international group engaged in the production, propagation, and genetic development of woody trees species and rootstocks for agricultural use, from Nazca.
- Shenzhen Energy Group acquires PV solar generation facilities from Recurrent Energy for $232 million - Advised Shenzhen Energy Group Co., Ltd. on its $232 million acquisition of a portfolio of PV solar generation facilities in California from Recurrent Energy, a wholly owned U.S. subsidiary of Canadian Solar.
- Kroger and Axium Pharmacy acquire ModernHEALTH to create combined specialty pharmacy - Advised The Kroger Co., world's largest grocer, and its specialty pharmacy subsidiary, Axium Pharmacy Holdings, Inc., in its acquisition of the outstanding shares of Modern HC Holdings, Inc. ("ModernHEALTH"), a leading specialty pharmacy, creating a combined specialty pharmacy that will operate as a wholly-owned subsidiary of The Kroger Co.
- AREVA sells subsidiary Canberra to Mirion-Charterhouse - Represented AREVA in the sale of its subsidiary, Canberra, a leading provider of innovative and cost-effective nuclear instrumentation solutions, to Mirion-Charterhouse.
- Bon Secours signs joint venture with Westchester Medical Center - Advised Bon Secours Health System, Inc. ("BSHSI"), a Catholic health system sponsored by Bon Secours Ministries with multiple hospitals and facilities across six states, and its subsidiary, Bon Secours Charity Health System, Inc. ("BSCHS"), a three-hospital health system north of New York City, with respect to the sale of its controlling interest in BSCHS to, and the creation of an ongoing joint venture arrangement with, Westchester Medical Center ("WMC").
- February 2015 - Revised and Revived: Mandatory Notifications for M&A Transactions in 2015, The M&A Lawyer, Vol. 19, Issue 2
- February 2014 - U.S. Antitrust Agencies Pursue Deals Reported Under Higher HSR Thresholds (And All The Others, Too), The M&A Lawyer, Vol. 18, Issue 1
- "Innovative Collaborations: Working Together without a Merger," American Health Lawyers Association Annual In-House Counsel Meeting, June 24, 2018, Chicago, Illinois
- "Medical Device vs. Pharmaceutical Markets -- Does One Size (i.e., Analysis) Fit All?" ABA Antitrust Section Healthcare and Pharmaceuticals Committee, February 15, 2018
- Antitrust in Healthcare Conference, American Health Lawyers Association and American Bar Association, May 13-14, 2014, Arlington, Virginia
- Health Law Symposium: The New Era of Healthcare Antitrust, American Health Lawyers Association and the Colorado Bar Association, March 15, 2014, Denver, Colorado
- "Managed Care Disputes and Litigation," American Conference Institute, October 21-23, 2013, Atlanta, Georgia
- "The Transformed U.S. Healthcare Landscape: Navigating the New Frontier," American University Washington College of Law, March 16, 2013, Washington, D.C.